Ansbert Gadicke
Equibles does not estimate personal net worth.
About Ansbert Gadicke
Earlier roles on record: Board Member at Cullinan Therapeutics, Inc. (CGEM) until November 1, 2022. Cullinan Therapeutics, Inc. reported in an 8-K filed November 2, 2022 that Ansbert Gadicke resigned as director, effective November 1, 2022.
“Also on November 1, 2022, Ansbert Gadicke, M.D. notified the Board of his intention to resign as a director effective as of November 1, 2022.”
Affiliation history
-
2016-01-01–2022-11-01